JAMA Oncology : Association of 5 α-Reductase Inhibitors With Prostate Cancer Mortality
Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 19, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
USPSTF Recommendation: Aspirin Use for Cardiovascular Disease
Interview with John B. Wong, MD, USPSTF member and coauthor of Aspirin Use for Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Deputy Editor Gregory Curfman, MD. Related Content: Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement Should Patients Take Aspirin for Primary Cardiovascular Prevention? USPSTF Review: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force Patie...
Source: JAMA Author Interviews - April 26, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Why do naked mole rats live as long as giraffes?
00:54 How Mammals’ mutation rates affects their lifespanFor biologists, a long-standing question has been why some animals live longer than others. This week a team have attempted to answer this, by measuring the rates that different animal species accumulate mutations. They show that longer-lived animals acquire mutations at a slower rate, which helps to explain why cancer risk does not scale with lifespan.Research article: Cagan et al.News and Views: Mutational clocks tick differently across species07:56 Research HighlightsA clinical trial suggests a change to the treatment of a pregnancy ailment, and astronomers ident...
Source: Nature Podcast - April 13, 2022 Category: Science Authors: Springer Nature Limited Source Type: podcasts
JAMA Oncology : Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer
Interview with Kenneth L. Kehl, MD, MPH, author of Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216). Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 17, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Dermatology : Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients
Interview with Michael R. Sargen, MD, author of Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US. Hosted by Adewole S. Adamson, MD, MPP. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 9, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
In conversation with... Verna Vanderpuye and Isabelle Soerjomataram
On this International Women's Day,Lancet editors and the co-chairs of the Women and Cancer Commission discuss the burden of women ’s cancer on society and reflect on the questions the Commission is trying to answer. (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 8, 2022 Category: General Medicine Authors: The Lancet Source Type: podcasts
JAMA Dermatology : Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Interview with Paul Nghiem, MD, PhD, author of Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. Hosted by Adewole S. Adamson, MD, MPP. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 23, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Racial Disparity in Survival Outcomes for Early Hormone Receptor –Positive Breast Cancer
Interview with Ruth C. Carlos, MD and Gelareh Sadigh, MD, authors of Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 17, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
259: Sea Sawdust
Mark Martin returns to TWiM for a discussion of the frightening global burden of bacterial antibiotic resistance, and a solution to the problem of daylight nitrogen fixation in a cyanobacterium, despite the incompatibility of nitrogenase with oxygen produced during photosynthesis. Become a patron of TWiM. Links for this episode: Global bacterial antimicrobial resistance (Nat Micro) Cancer moon shot (NCI) When antibiotics don’t work (TED) Cyanobacterium buoyancy (Nat Micro) Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Send your microbiology questions and comments to twim@microbe...
Source: This Week in Virology - MP3 Edition - February 11, 2022 Category: Virology Authors: Vincent Racaniello, Elio Schaechter, Michele Swanson, Michael Schmidt, Mark O. Martin Source Type: podcasts
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Diabetes Core Update – February 2022
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - January 29, 2022 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC
Interview with Heather Jacene MD, and Jonathan D. Schoenfeld, MD, MPH, authors of Use of Fluoro-[F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers Hosted by Joseph P. Bradley, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 20, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Medical Oncology Depression Screening for Breast Cancer, Anesthesia Choice and Postoperative Delirium After Hip Fracture Surgery, Maternal Hormone Contraception and CNS Tumors in Children, and more
Editor’s Summary by Linda Brubaker, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 4, 2022 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 4, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
In conversation with... Nick James
Nick James discusses the key messages of the recent report from the STAMPEDE trial platform and the success of this platform in advancing the treatment of prostate cancer. (Source: Listen to The Lancet)
Source: Listen to The Lancet - December 23, 2021 Category: General Medicine Authors: The Lancet Source Type: podcasts
Can music interventions benefit people with cancer?
Music therapy is used for a variety of conditions and several Cochrane Reviews examine its effects. A team of music therapists with expertise in the use of music therapy with medical patients updated their review for cancer patients in October 2021. Joke Bradt from the department of Creative Arts Therapies at Drexel University in Philadelphia, USA tells us what they found in this Evidence Pod. She conducted the review with Cheryl Dileo from Temple University in Philadelphia, Katherine Myers-Coffman from Molloy College in Rockville Center, and Jacelyn Biondo, postdoctoral fellow in the department of Creative Arts Therapies ...
Source: Podcasts from The Cochrane Library - November 29, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
